Problems and prospects in the use of lym
β
G. T. Stevenson; M. J. Glennie; T. J. Hamblin; A. C. Lane; F. K. Stevenson
π
Article
π
1988
π
John Wiley and Sons
π
French
β 364 KB
The infusion of anti-idiotypic antibody in patients with lymphoma has proved a relatively innocuous procedure, but in general has yielded only partial, short-lived remissions of disease. A major problem is that xenogeneic antibody is simply not well-fitted t o destroying mammalian cells: complement